[1]熊正平,张阳德,黄芳,等.前列腺癌放射治疗进展[J].国际放射医学核医学杂志,2007,31(1):58-60.
　XIONG Zheng-ping,ZHANG Yang-de,HUANG Fang,et al.Advances in radiation therapy for prostate cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2007,31(1):58-60.
点击复制

前列腺癌放射治疗进展(/HTML)
分享到：

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
31
期数:
2007年第1期
页码:
58-60
栏目:
临床放射医学
出版日期:
1900-01-01

文章信息/Info

Title:
Advances in radiation therapy for prostate cancer
作者:
熊正平1; 2;  张阳德2;  黄芳3;  梁赵玉1;  杨树仁4
1. 410013 长沙, 湖南省肿瘤医院放射科;
2. 410008 长沙, 卫生部肝胆肠外科研究中心;
3. 410013 长沙, 中南大学湘雅三医院感染科;
4. 410013 长沙, 湖南省肿瘤医院放射科
Author(s):
XIONG Zheng-ping1; 2;  ZHANG Yang-de2;  HUANG Fang3;  LIANG Zhao-yu1;  YANG Shu-ren4
1. Department of Radiology, Hunan Tumor Hospital, Changsha 410013, China;
2. National Hepatobiliary and Enteric Surgery Research Center, Changsha 410008, China;
3. Department of Infection, Third Hospital of Xiangya, Changsha 410013, China;
4. Dep
关键词:
前列腺肿瘤; 放射疗法; 计算机辅助; 磁共振成像
Keywords:
Prostatic neoplasms; Radiotherapy;  computer-assisted; Magnetic resonance imaging
分类号:
R730.55
摘要:
现代计算机技术推动医学影像技术高速发展,高水平的图像技术又推动放射治疗计划系统进入到更复杂、更高水平。放射治疗计划的设计由原来的二维图像和人工计算发展到了X射线图像和复杂的计算机运算。在治疗过程中,由于肿瘤代谢、抗原的差别,已经考虑到其与正常组织不同的生物学变量,使执行治疗计划时更加精确,如摆位误差、器官运动等已被全面系统地考虑,故又称四维放射治疗。
Abstract:
Modern advances in computers have fueled advances in imaging technologies. The improvements in imaging have in turn allowed a higher level of complexity to be incorporated into radiotherapy treatment planning systems. As a result of these changes, the delivery of radiotherapy evolved from therapy designed based primarily on plain (two dimensional) X-ray images and hand calculations to three-dimensional X-ray based images incorporating increasingly complex computer algorithms. More recently, biologic variables based on differences between tumor metabolism, tumor antigens, and normal tissues have been incorporated into the treatment process. In addition, greater awareness of the challenges to the accuracy of the treatment planning process, such as problems with set-error and organ movement, have begun to be systematically addressed, ushering in an era of socalled four-dimensional radiotherapy.

参考文献/References:

1 Barker JL Jr, Garden AS, Ang KK, et al. Quantification of volumetric and geometric changes occurring during fractionated radiotherapy for head and neck cancer using an integrated CT/linear accelerator system. Int J Radiat Oncol Biol Phys, 2004, 59(4):960-970.
2 Hansen EK, Bucci MK, Quivey JM, et al. Repeat CT imaging and replanning during the course of IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys, 2006, 64(2):355-362.
3 Pouliot J, Bani-Hashemi A, Chen J, et al. Low-dose megavoltage cone-beam CT for radiation therapy. Int J Radiat Oncol Biol Phys,2005, 61(2):238-241.
4 Jani AB, Parikth SD, Vijayakumar S, et al. Analysis of influence of age on acute and chronic radiotherapy toxicity in treatment of prostate cancer. Urology, 2005, 65(6):1157-1162.
5 Kupelian PA, Potters aL, Khuntia D, et al. Radical prostatectomy,external beam radiotherapy <72GY, external beam radiotherapy 72GY, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1-T2 prostate cancer. Int J Radiat Oncol Biol Phys, 2004, 58(1):25-33.
6 Michalski JM, Winter K, Purdy JA, et al. Toxicity after three-dimensional radiotherapy for prostate cancer with RTOG 9406 dose level Ⅳ. Int J Radiat Oncol Biol Phys, 2005, 62(3):706-713.
7 Zelefsky MJ, Fuks Z, Hunt M, et al. High-dose intensity modulated radiation therapy for prostate cancer, early toxicity and biochemical outcome in 772 patients. Int J Radiat Oncol Biol Phys, 2002, 53(5):1111-1116.
8 Ashman JB, Zelefsky MJ, Hunt MS, et al. Whole pelvic radiotherapy for prostate cancer using 3D conformal and intensity modulated radiotherapy. Int J Radiat Oncol Biol Phys, 2005, 63(3):765-771.
9 Jani AB, Blend MJ, Hamilton R, et al. Radioimmunoscintigraphy for postprostatectomy radiotherapy:analysis of toxicity and biochemical control. J Nucl Med, 2004, 45(8):1315-1322.
10 Schettino CJ, Kramer EL, Noz ME, et al. Impact of fusion of indium-111 capromab pendetide volume data sets with those from MRI or CT in patients with recurrent prostate cancer. AIR, 2004,183(2):519-524.
11 Jackson AS, Parker CC, Norman AR, et al, Tumor staging using magnetic resonance imaging in clinically localized prostate cancer:relationship to biochemical outcome after neo-adjuvant androgen deprivation and radical radiotherapy. Clin Oncol (R Coll Radiol),2005, 17(3):167-171.
12 Pickett B, Ten Haken RK, Kurhanewicz J, et al. Time to metabolic atrophy after permanent prostate seed implantation based on magnetic resonance spectroscopic imaging. Int J Radit Oncol Biol Phys,2004, 59(3):665-673.
13 Ganswindt U, Paulsen F, Anastasiadis AG, et al. 70 Gy or more:which dose for which prostate cancer?. J Cancer Res Clin Oncol,2005, 131(7):407-419.
14 Langen KM, Pouliot J, Anezinos C, et al. Evaluation of ultrasound-based prostate localization for image-guided radiotherapy. Int J Radiat Oncol Biol Phys, 2003, 57(3):635-644.
15 Pouliot J, Aubin M, Langen KM, et al. (Non)-migration of radiopaque markers used for on-line localization of the prostate with an electronic.portal imaging device. Int J Radiat Oncol Biol Phys,2003, 56(3):862-866.
16 Niehoff P, Loch T, Numberg N, et al. Feasibility and preliminary outcome of salvage combined HDR braehytherapy and external beam radiotherapy (EBRT) for local recurrences after radical prostatectomy. Braehytherapy, 2005, 4(2):141-145.
17 Michalski JM, Winter K, Purdy JA, et al. Preliminary evaluation of low-grade toxicity with conformal radiation therapy for prostate cancer on RTOG 9406 dose levels Ⅰ and Ⅱ. Int J Radiat Oncol Biol Phys, 2003, 56(1):192-198.

相似文献/References:

[1]李景涛,邓垒,张文珏,等.广泛期小细胞肺癌胸部IMRT后发生放射性肺炎的危险因素分析[J].国际放射医学核医学杂志,2016,40(2):100.[doi:10.3760/cma.j.issn.1673-4114.2016.02.003]
　Li Jingtao,Deng Lei,Zhang Wenjue,et al.Risk factor analysis for predicting radiation pneumonitis in extensive stage small cell lung cancer patients receiving IMRT thoracic radiotherapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):100.[doi:10.3760/cma.j.issn.1673-4114.2016.02.003]
[2]刘佳,高刚,朴春南,等.调节肿瘤放射敏感性的miRNAs研究进展[J].国际放射医学核医学杂志,2016,40(2):159.[doi:10.3760/cma.j.issn.1673-4114.2016.02.015]
　Liu Jia,Gao Gang,Piao Chunnan,et al.Progress of microRNAs in regulating tumor radiation sensitivity[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):159.[doi:10.3760/cma.j.issn.1673-4114.2016.02.015]
[3]陈晓艳,张江虹,邵春林.STAT3与辐射敏感相关性的研究进展[J].国际放射医学核医学杂志,2016,40(3):191.[doi:10.3760/cma.j.issn.1673-4114.2016.03.007]
　Chen Xiaoyan,Jianghong,Shao Chunlin.Research progresses of correlation between STAT3 and radiosensitivity[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):191.[doi:10.3760/cma.j.issn.1673-4114.2016.03.007]
[4]赵德云,李百龙.植物提取物防治放射性肺损伤的现状与展望[J].国际放射医学核医学杂志,2016,40(3):208.[doi:10.3760/cma.j.issn.1673-4114.2016.03.010]
　Zhao Deyun,Li Bailong.Protective and therapeutic effects of plant extracts on radiation-induced lung injury:present status and future prospects[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):208.[doi:10.3760/cma.j.issn.1673-4114.2016.03.010]
[5]田琦,蒋宁一,郑丽.265例精细个体化131I治疗Graves甲亢的疗效观察[J].国际放射医学核医学杂志,2016,40(4):259.[doi:10.3760/cma.j.issn.1673-4114.2016.04.004]
　Tian Qi,Jiang Ningyi,Zheng Li.Therapeutic effect of fine individual 131I treatment on Graves disease hyperthyroidism[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):259.[doi:10.3760/cma.j.issn.1673-4114.2016.04.004]
[6]邓大平,卢峰,孙洪强,等.颅脑肿瘤放射治疗时射野外器官吸收剂量体模法测量与分析[J].国际放射医学核医学杂志,2016,40(4):272.[doi:10.3760/cma.j.issn.1673-4114.2016.04.007]
　Deng Daping,Lu Feng,Sun Hongqiang,et al.Test and analysis of out-of-field organ dose in intracranial tumor radiotherapy using phantom[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):272.[doi:10.3760/cma.j.issn.1673-4114.2016.04.007]
[7]王朋,崔邦平,代文莉,等.18F-FDG PET/CT在前列腺癌中的应用进展[J].国际放射医学核医学杂志,2016,40(4):277.[doi:10.3760/cma.j.issn.1673-4114.2016.04.008]
　Wang Peng,Cui Bangping,Dai Wenli,et al.Progress in the application of 18F-FDG PET/CT in prostate cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):277.[doi:10.3760/cma.j.issn.1673-4114.2016.04.008]
[8]赵舒怡,储小飞,樊赛军.血清肿瘤标志物与肿瘤放疗疗效评估的研究进展[J].国际放射医学核医学杂志,2015,39(5):427.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 018]
　zhao shuyi,chu xiaofei,fan saijun..progression of study on serum tumor markers in evaluation of tumor radiotherapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(1):427.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 018]
[9]赵徵鑫,翟贺争,张文艺,等.质子重离子治疗肿瘤的进展[J].国际放射医学核医学杂志,2016,40(5):384.[doi:10.3760/cma.j.issn.1673-4114.2016.05.010]
　Zhao Zhixin,Zhai Hezheng,Zhang Wenyi,et al.Development of proton heavy ion in tumor therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):384.[doi:10.3760/cma.j.issn.1673-4114.2016.05.010]
[10]廖光星,冷志欣,肖国有.前列腺癌骨转移影像诊断方法研究进展[J].国际放射医学核医学杂志,2016,40(6):464.[doi:10.3760/cma.j.issn.1673-4114.2016.06.012]
　Liao Guangxing,Leng Zhixin,Xiao Guoyou.Progress of imaging in the diagnosis of bone metastases of prostate cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):464.[doi:10.3760/cma.j.issn.1673-4114.2016.06.012]
[11]刘辰,杨悦,张雪宁,等.CT/MRI图像融合在前列腺癌IMRT中的应用进展[J].国际放射医学核医学杂志,2014,38(4):247.[doi:10.3760/cma.j.issn.1673-4114.2014.04.010]
　Liu Chen,Yang Yue,Zhang Xuening,et al.CT/MRI image fusion in intensity modulated radiation therapy for prostate cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(1):247.[doi:10.3760/cma.j.issn.1673-4114.2014.04.010]

备注/Memo

备注/Memo:
收稿日期:2006-03-27。
通讯作者:熊正平,E-mail:xiongzhengping126@126.com
更新日期/Last Update: 1900-01-01